Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea

Journal of Clinical Microbiology

Volumn 42, Issue 7, 2004, Pages 3306-3308

  Uh, Young ^a   Jang, In Ho ^a   Hwang, Gyu Yel ^a   Lee, Mi Kyung ^a   Yoon, Kap Jun ^a   Kim, Hyo Youl ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INFECTION PREVENTION; KOREA; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENOTYPE; MEMBRANE PROTEINS; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 3142663195     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.7.3306-3308.2004     Document Type: Article

References (22)

1. Andrews, J. I., D. J. Diekema, S. K. Hunter, P. R. Rhomberg, M. A. Pfaller, R. N. Jones, and G. V. Doern. 2000. Group B streptococci causing neonatal blood stream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am. J. Obstet. Gynecol. 183:859-862.
2. Baker, C. J., B. J. Webb, and F. F. Barrett. 1976. Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob. Agents Chemother. 10:128-131.
3. Betriu, C., E. Culebras, M. Gómez, I. Rodríguez-Avial, B. A. Sánchez, M. C. Ágreda, and J. J. Picazo. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47:1112-1114.
4. Blumberg, H. M., D. S. Stephens, M. Modansky, M. Erwin, J. Elliot, R. R. Facklam, A. Schuchat, W. Baughman, and M. M. Farley. 1996. Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173:365-373.
5. Croak, A., G. Abate, K. Goodrum, and M. Modrzakowski. 2003. Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am. J. Obstet. Gynecol. 188:1148-1150.
6. de Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
7. Diekema, D. J., J. I. Andrews, H. Huynh, P. R. Rhomberg, S. R. Doktor, J. Beyer, V. D. Shortridge, R. K. Flamm, R. N. Jones, and M. A. Pfaller. 2003. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J. Clin. Microbiol. 41:2659-2661.
8. Elliott, J. A., K. D. Farmer, and R. R. Facklam. 1998. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J. Clin. Microbiol. 36:2115-2116.
9. Farley, M. M. 2001. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33:556-561.
10. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517-1519.
11. Fitoussi, F., C. Loukil, I. Gros, O. Clermont, P. Mariani, S. Bonacorsi, I. Le Thomas, D. Deforche, and E. Bingen. 2001. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob. Agents Chemother. 45:1889-1891.
12. Kataja, J., P. Huovinen, M. Skurnik, the Finnish Study Group for Antimicrobial Resistance, and H. Seppälä. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
13. Ko, W. C., H. C. Lee, L. R. Wang, C. T. Lee, A. J. Liu, and J. J. Wu. 2001. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 20:334-339.
14. Lee, K., J. W. Shin, Y. Chong, and H. Mikamo. 2000. Trends in serotypes and antimicrobial susceptibility of group B streptococci isolated in Korea. J. Infect. Chemother. 6:93-97.
15. Lin, F.-Y., P. H. Azimi, L. E. Weisman, J. B. Philips, J. Regan, P. Clark, G. G. Rhoads, J. Clemens, J. Troendle, E. Pratt, R. A. Brenner, and V. Gill. 2000. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. Dis. 31:76-79.
16. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial susceptibility testing - thirteenth informational supplement. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Sutcliffe, J., T. Grebe, A. Tait-Karnradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
18. Traub, W. H., and B. Leonhard. 1997. Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43:10-20.
19. Tyrrell, G. J., L. D. Senzilet, J. S. Spika, D. A. Kertesz, M. Lovgren, J. A. Talbot, and the Sentinel Health Unit Surveillance System Site Coordinators. 2000. Invasive disease due to group B streptococcal infection in adults: results from Canadian, population-based, active laboratory surveillance study - 1996. J. Infect. Dis. 182:168-173.
20. Uh, Y., I. H. Jang, G. Y. Hwang, K. J. Yoon, and W. Song. 2001. Emerging erythromycin resistance among group B streptococci in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 20:52-54.
21. von Both, U., M. Ruess, U. Mueller, K. Fluegge, A. Sander, and R. Berner. 2003. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J. Clin. Microbiol. 41:2166-2169.
22. Wu, J.-J., K.-Y. Lin, P.-R. Hsueh, J.-W. Liu, H.-I. Pan, and S.-M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.